Partnerships decreased significantly in the medical industry in H2 2021

Partnerships in the medical sector have seen a decrease of 50% from H2 2020 to H2 2021, an analysis of GlobalData's deals database reveals.

Powered by 

In the second half of 2021 the number of partnerships decreased significantly by 50% from the same period in 2020.

This marks a deceleration in growth from the 5.8% decrease in deals that occurred in H1 2021 relative to the same period a year earlier.

During second half of 2021, partnerships accounted for 14.5% of all deals taking place in the sector. This represents a decrease from the figure of 24% in second half of 2020.

GlobalData's deals database is a comprehensive repository that looks at mergers, acquisitions, venture financing, equity offerings, asset transactions, partnerships and debt offerings taking place daily between thousands of companies across the world.

The database details key deal information, such as deal summary, deal rationale, deal financials, parties involved, advisors and deal payment modes.

By tracking the proportion of various types of deals in each sector we can gauge which sectors are seeing growth and where others are struggling.